Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model

International Journal of Antimicrobial Agents

Volumn 31, Issue 2, 2008, Pages 182-184

  Delgado, Olinda M ^a   Fernandez, Glory ^a   Silva, Sylvia ^a   Ramirez, Oriana ^a   Romero, Jesus ^b   Rodriguez Morales, Alfonso J ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Fundación de Protección Animal del Municipio Libertador   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN; NITAZOXANIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; LARVA; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXOCARA CANIS; TOXOCARIASIS; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; THIAZOLES; TOXOCARA CANIS; TOXOCARIASIS;

EID: 37549028395     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.10.008     Document Type: Letter

References (5)

1. Hotez P.J., Molyneux D.H., Fenwick A., et al. Control of neglected tropical diseases. N Engl J Med 357 (2007) 1018-1027
2. Renslo A.R., and McKerrow J.H. Drug discovery and development for neglected parasitic diseases. Nat Chem Biol 2 (2006) 701-710
3. Delgado O., Botto C., Mattei R., and Escalante A. Effect of albendazole in experimental toxocariasis of mice. Ann Trop Med Parasitol 83 (1989) 621-624
4. Hemphill A., Mueller J., and Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7 (2006) 953-964
5. White Jr. C.A. Nitazoxanide: a new broad spectrum antiparasitic agent. Expert Rev Anti Infect Ther 2 (2004) 43-49